365NEWSX
365NEWSX
Subscribe

Welcome

Research on COVID-19 Vaccination Technology Could Lead to HIV, Cancer Vaccines - Newsweek

Research on COVID-19 Vaccination Technology Could Lead to HIV, Cancer Vaccines - Newsweek

Research on COVID-19 Vaccination Technology Could Lead to HIV, Cancer Vaccines - Newsweek
Jan 23, 2021 1 min, 3 secs

Vaccines currently being used to prevent COVID-19 were developed with a newer technique that scientists are attempting to use to produce vaccines for HIV, cancer and other ailments.

Although scientists have been working to develop mRNA vaccines and therapies for decades, the COVID-19 vaccines are the first ever to be approved for use in humans.

The rapid development and emergency approval of the COVID-19 vaccines happened both due to massive monetary investments in vaccine production efforts and the good fortune of the pandemic coming at just the time when mRNA technology had become sufficiently advanced to produce a safe and effective vaccine.

The success has inspired companies to accelerate efforts at using the mRNA technique to tackle a host of other diseases, with Moderna announcing three new vaccine projects earlier this month.

The new mRNA vaccines prompt the body to produce the virus protein, which in the case of COVID-19 is the "spike" protein that the coronavirus uses to infect cells, without using any of the actual virus.

BioNTech is also using the mRNA platform to develop new experimental cancer therapies.

The mRNA technique is being used to develop vaccines and therapies against several other viruses, with trials having either been conducted or underway for Zika, cytomegalovirus and rabies vaccines.

Summarized by 365NEWSX ROBOTS

RECENT NEWS

SUBSCRIBE

Get monthly updates and free resources.

CONNECT WITH US

© Copyright 2024 365NEWSX - All RIGHTS RESERVED